Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus

QR Code

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus

Pamela KushnerUniversity of California, Irvine College of Medicine, California, USAAbstract: Hypoglycemia is a major barrier to achieving glycemic goals in patients with diabetes. Both acute and chronically recurrent hypoglycemic events appear to have long-term consequences for patients with type 2...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Pamela Kushner
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2010
Sujets:	Specialties of internal medicine RC581-951
Accès en ligne:	https://doaj.org/article/b0c502d246c044ddaf6ada5c4b0b8245
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus
par: Kushner P
Publié: (2010)

Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia
par: Anderson M, et autres
Publié: (2014)

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
par: Lorber D
Publié: (2014)

A psychometric evaluation of the Diabetes Symptom Checklist-Revised (DSC-R) cognitive distress, fatigue, hyperglycemia, and hypoglycemia subscales in patients with type 1 and type 2 diabetes
par: April N Naegeli, et autres
Publié: (2010)

Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
par: Alaa Badawi, et autres
Publié: (2010)

Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
par: Kedia N
Publié: (2011)

Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus
par: Feher M, et autres
Publié: (2013)

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
par: Omoto S, et autres
Publié: (2015)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated
par: Irons BK, et autres
Publié: (2014)

Association Between Knowledge of Hypoglycemia and Likelihood of Experiencing Hypoglycemia Among Patients with Insulin-Treated Diabetes Mellitus
par: Almigbal TH
Publié: (2021)

Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
par: Ogedengbe OS, et autres
Publié: (2015)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
par: Irons BK, et autres
Publié: (2017)

Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus
par: Mazzilli R, et autres
Publié: (2015)

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
par: Shannon A Miller, et autres
Publié: (2009)

Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management
par: Nitzan O, et autres
Publié: (2015)

Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin
par: Ohira M, et autres
Publié: (2014)

Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus
par: Konya H, et autres
Publié: (2013)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
par: Holl, et autres
Publié: (2014)

Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review
par: Colosia AD, et autres
Publié: (2013)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
par: Stanley Schwartz, et autres
Publié: (2010)

Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus
par: Petersen AB, et autres
Publié: (2013)

Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions
par: Angel Rodr&iacute;guez, et autres
Publié: (2010)

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]
par: Wilke T, et autres
Publié: (2019)

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
par: Jason Seewoodhary, et autres
Publié: (2010)

Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting
par: Ofori SN, et autres
Publié: (2014)

Risk management in the treatment of type 2 diabetes with pioglitazone
par: Giuseppe Derosa, et autres
Publié: (2009)

Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements
par: Yang F, et autres
Publié: (2015)

Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase&ndash;lowering effects of garlic in patients with type 2 diabetes mellitus with obesity
par: Kumar R, et autres
Publié: (2013)

Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
par: Peter J Donovan, et autres
Publié: (2010)

Glucose estimation in the salivary secretion of diabetes mellitus patients
par: Abikshyeet P, et autres
Publié: (2012)

Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study
par: Penfornis A, et autres
Publié: (2015)

Long-term (52&ndash;78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients
par: Bays HE
Publié: (2012)

Using the health action process approach to predict and improve health outcomes in individuals with type 2 diabetes mellitus
par: MacPhail M, et autres
Publié: (2014)

Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study
par: Usharani P, et autres
Publié: (2013)

Evidence for the benefit of exercise therapy in patients with type 2 diabetes
par: Madden KM
Publié: (2013)

Insulin detemir for the treatment of obese patients with type 2 diabetes
par: Hollander PA
Publié: (2012)

Red cell distribution width in type 2 diabetic patients
par: Nada AM
Publié: (2015)

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review
par: Gregory E Peterson
Publié: (2009)

Management of gestational diabetes mellitus
par: Annunziata Lapolla, et autres
Publié: (2009)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
par: Stanley S Schwartz
Publié: (2010)